POPULARITY
3 episodes with assisted reproduction
2 episodes with assisted reproduction
4 episodes with assisted reproduction
5 episodes with assisted reproduction
2 episodes with assisted reproduction
2 episodes with assisted reproduction
2 episodes with assisted reproduction
2 episodes with assisted reproduction
2 episodes with assisted reproduction
Told it's impossible? Let's change that.In this episode, I break down what your AMH (Anti-Müllerian Hormone) levels really mean for your fertility — and why a low AMH is not the final word on your chances of getting pregnant.➡️ What you'll learn in this episode:✅ What AMH actually measures (and what it doesn't)✅ The surprising role of AMH as a “dam” in your ovarian function✅ Why are many women being misled by this one number✅ The difference between egg quantity vs. quality✅ Natural, research-backed strategies to support your fertility — even with low AMH
Medical interventions in fertility have transformed how people experience parenthood. How can clinicians navigate the intricate emotional landscape created by assisted reproduction? In this episode, Renata Viola Vives and Ana Teresa Vale explore the complex relationship between assisted reproduction and psychoanalysis, drawing from their edited book, "Pregnancy, Assisted Reproduction and Psychoanalysis," published by Routledge. Conceived through years of clinical work and shaped by the collaborative encounters fostered by COWAP, the IPA Women and Psychoanalysis Committee, they explore how contemporary practices redefine our understanding of parenthood, identity, and desire. Drawing on their extensive experience, the authors address the historical tensions between psychoanalysis and reproductive technologies, and highlight the need for a nuanced approach. By examining the emotional impact of procedures like gàmete donation and sùrrogacy, they emphasize the importance of understanding the anxieties and fantasies that accòmpany these kinds of journeys to parenthood. Renata Viola Vives is a Clinical Psychologist and Psychoanalyst, a member of the Brazilian Society of Psychoanalysis in Porto Alegre, and currently COWAP's Latin-American representative. She is an editor and organizer of books on parenting, assisted reproduction, and adoption. Ana Teresa Vale is a Clinical Psychologist and a Psychoanalyst, member of the Portuguese Psychoanalytic Society, teaching in her Society's training program. She is Assistant Director of the Portuguese Psychoanalytic Journal, and currently COWAP's European representative. This episode is presented in English, Portuguese, Spanish, and French. The English version is read by Ana Teresa Vale. french portuguese spanish This Podcast Series, published by the International Psychoanalytical Association, is part of the activities of the IPA Communication Committee and is produced by the IPA Podcast Editorial Team. Co-Editors: Gaetano Pellegrini and Nicolle Zapien. Editing and Post-Production: Massimiliano Guerrieri. To stay informed about the latest podcast releases, please sign up today.
Les interventions médicales dans le domaine de la fertilité ont transformé la façon dont les gens vivent la parentalité. Comment les cliniciens peuvent-ils naviguer dans le paysage émotionnel complexe créé par la reproduction assistée ?Dans cet épisode, Renata Viola Vives et Ana Teresa Vale explorent la relation complexe entre la procréation assistée et la psychanalyse, en s'appuyant sur leur ouvrage intitulé « Pregnancy, Assisted Reproduction and Psychoanalysis » (Grossesse, procréation assistée et psychanalyse), publié par Routledge. Conçues au fil d'années de travail clinique et façonnées par les rencontres collaboratives encouragées par le COWAP, le Comité Femmes et Psychanalyse de l'IPA, elles explorent la manière dont les pratiques contemporaines redéfinissent notre compréhension de la parentalité, de l'identité et du désir.S'appuyant sur leur vaste expérience, les auteurs abordent les tensions historiques entre la psychanalyse et les technologies de reproduction, et soulignent la nécessité d'une approche nuancée. En examinant l'impact émotionnel de procédures telles que le don de gàmete et la sùrrogacy, ils soulignent l'importance de comprendre les angoisses et les fantasmes qui accompagnent ces types de parcours vers la parentalité. Renata Viola Vives est psychologue clinicienne et psychanalyste, membre de la Société brésilienne de psychanalyse à Porto Alegre, et actuellement représentante du COWAP pour l'Amérique latine. Elle est éditrice et organisatrice de livres sur la parentalité, la reproduction assistée et l'adoption.Ana Teresa Vale est psychologue clinicienne et psychanalyste, membre de la Société portugaise de psychanalyse, et enseigne dans le programme de formation de cette société. Elle est directrice adjointe du Journal psychanalytique portugais et représente actuellement le COWAP en Europe. Cet épisode est présenté en anglais, portugais, espagnol et français. La version française est lue par Ana Teresa Vale. Introduction lue par Bianca Cerrina Feroni.Cette série de podcasts, publiée par l'Association psychanalytique internationale, fait partie des activités du Comité de communication de l'IPA et est produite par l'équipe éditoriale des podcasts de l'IPA. A la direction de l'équipe éditoriale : Gaetano Pellegrini et Nicolle ZapienIngénieur du son : Massimilano Guerrieri
Economist and CEO of ParentData Emily Oster returns, this time dispelling myths and shedding light into the complexities of fertility. She discusses what does and doesn’t affect sperm and eggs, the science behind egg freezing, the impact of stress on fertility, and much more. See omnystudio.com/listener for privacy information.
In his weekly clinical update, Dr. Griffin and Vincent Racaniello discuss confirmation of Robert F Kennedy as HHS sectary, mpox, Ebola, how the American people support vaccine development and administration, the measles outbreak in the US-Texas, Georgia and influenza: the number of human infections, high avian flu in mammals, house cats and dairy cows before Dr. Griffin reviews recent statistics on RSV, influenza and SARS-CoV-2 infections, the WasterwaterScan dashboard, where to find PEMGARDA, an update of Paxlovid administration provides information for Columbia University Irving Medical Center's long COVID treatment center, where to go for answers to your long COVID questions, how long COVID varies between children and adults and if viral infection reduces telomere length in sperm. Subscribe (free): Apple Podcasts, RSS, email Become a patron of TWiV! Links for this episode Confirmation of RFK, Jr as HHS sect (NY Times) Did you know mpox in NY?….(Reuters) Mpox in sex workers in the Congo and in NY (CIDRAP) 9 confirmed, 265 suspected Ebola cases in Uganda (AP news) WHAT!? Support vaccines: availability and development. WHAT? (Businesswire) Measles rising in the unvaccinated. You mean the vaccines does something positive? (ABC News) Measles in Texas….go big or go home (Texas Health and Human Services) Vaccination Conscientious exemptions in Texas (Texas Health and Human Services) 2, 6, 14 measles hospitalizations in Texas (CNN) Decreases in childhood vaccinations SchoolVaxView(CDC) 2 when 24 cases of measles in two weeks (Texas Health and Human Services) Measles in small town Texas (NY Times) Measles in the US Texas, Georgia, Rhode Island, New York, New Mexico: Elimination of measles (JID) Influenza taxonomy (NCBI) H5N9 in commercial duck farm, California (American Animal Hospital Association) Second type of bird flu circulating in ducks (Scientific Amercia) Variant H1N2 flu in Iowa (CIDRAP) All types of influenza (CDC Influenza) Bird flu in the zoos: Bronx and Queens (Gothamist) High path avian influenza in mammals (USDA: Animal and plant health inspection service) Bird flu in house cats…..I tawt I taw a puddy tat (KFF Health News) New strain of influenza in dairy cows (AP News) Influenza: Waste water scan for 11 pathogens (WastewaterSCan) How the communications pause endangered us about influenza (AP News) Most intense flu season in 15 years (AP News)US respiratory virus activity (CDC Respiratory Illnesses) Weekly surveillance report: clift notes (CDC FluView) RSV: Waste water scan for 11 pathogens (WastewaterSCan) Weekly US influenza surveillance report (CDC FluView) RSV-Network (CDC Respiratory Syncytial virus Infection) 10 year surveillance of RSV hospitalization in adults(JID) Seasonality of RSV: 2017-2023(CDC: MMWR) What doctors wish patients know about RSV (AMA) US respiratory virus activity (CDC Respiratory Illnesses) Waste water scan for 11 pathogens (WastewaterSCan) COVID-19 deaths (CDC) COVID-19 national and regional trends (CDC) COVID-19 variant tracker (CDC) SARS-CoV-2 genomes galore (Nextstrain) Where to get pemgarda (Pemgarda) EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD) Fusion center near you….if in NY (Prime Fusions) CDC Quarantine guidelines (CDC) NIH COVID-19 treatment guidelines (NIH) Drug interaction checker (University of Liverpool) Paxlovid update (Pfizer) Infectious Disease Society guidelines for treatment and management (ID Society) Molnupiravir safety and efficacy (JMV) Convalescent plasma recommendation for immunocompromised (ID Society) What to do when sick with a respiratory virus (CDC) When your healthcare provider is infected/exposed with SARS-CoV-2 (CDC) Managing healthcare staffing shortages (CDC) Steroids, dexamethasone at the right time (OFID) Anticoagulation guidelines (hematology.org) Daniel Griffin's evidence based medical practices for long COVID (OFID) Long COVID hotline (Columbia : Columbia University Irving Medical Center) The answers: Long COVID Proportion of Long COVID incidence in adults and children (CID) SARS-CoV-2 infection effects sperm telomere length (Journal of Assisted Reproduction and Genetics) Pediatric gastrointestinal tract outcomes during the postacute phase of COVID-19c] (JAMA Network) Letters read on TWiV 1192 Dr. Griffin's COVID treatment summary (pdf) Timestamps by Jolene Ramsey. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
Reprodução Humana Assistida (SciCast #631) Patronato do SciCast: 1. Patreon SciCast 2. Apoia.se/Scicast 3. Nos ajude via Pix também, chave: contato@scicast.com.br ou acesse o QRcode: Sua pequena contribuição ajuda o Portal Deviante a continuar divulgando Ciência! Contatos: contato@scicast.com.br https://twitter.com/scicastpodcast https://www.facebook.com/scicastpodcast https://instagram.com/scicastpodcast Fale conosco! E não esqueça de deixar o seu comentário na postagem desse episódio! Expediente: Produção Geral: Tarik Fernandes e André Trapani Equipe de Gravação: André Trapani, Marcelo de Matos, Gabriel Lima, Natalia Nakamura, Daniele Perondi, Letícia Aguiar Citação ABNT: Scicast #631: Reprodução Humana Assistida. Locução: André Trapani, Marcelo de Matos, Gabriel Lima, Natalia Nakamura, Daniele Perondi, Letícia Aguiar . [S.l.] Portal Deviante, 15/02/2025. Podcast. Disponível em: https://www.deviante.com.br/podcasts/scicast-631 Imagem de capa: Referências e Indicações Sugestões de literatura: Bioética e reprodução assistida. Infertilidade, produção e uso de embriões humanos. In: LOYOLA, M. A. (Org). Bioética, reprodução e gênero nas sociedades contemporâneas Campinas e Brasília: Abep e Letras-Livres, 2005ª. CORRÊA A, M. C. D. V. A tecnologia a serviço de um sonho. Um estudo da reprodução assistida no Brasil. Tese (doutorado em Saúde Coletiva) - Instituto de Medicina Social, Universidade do Estado do Rio de Janeiro. Rio de Janeiro, 1997. MEIRA, A. R. Reprodução humana: a ética trinta anos depois. Revista Bioética, v. 16, n. 1, 2008. CORRÊA, Marilena C.D.V.; LOYOLA, Maria Andrea. Assisted reproductive technologies in Brazil: Options to improve access. Physis, [s. l.], v. 25, n. 3, p. 753–777, 2015. STEPTOE, P. C.; EDWARDS, R. G. Birth after the reimplantation of a human embryo. Archives of Pathology and Laboratory Medicine, [s. l.], v. 116, n. 4, p. 321, 1992. VAYENA, Effy; ROWE, Patrick J.; GRIFFIN, P. David. Current challenges in assisted reproduction. In: , 2002. Medical, Ethical and Social Aspects of Assisted Reproduction (2001: Geneva, Switzerland) Current practices and controversies in assisted reproduction : report of a WHO meeting / editors. [S. l.: s. n.], 2002. Sugestões de filmes: A estranha vida de Timothy Green Minhas mães e meu pai Gataca Sugestões de vídeos: Via Justiça - Biodireito, Bioética e Direitos Humanos - 1º Bloco Sugestões de links: Óvulo criado a partir de gametas masculinos https://jstories.media/article/mouse-ips See omnystudio.com/listener for privacy information.
Rabbi Breitowitz- Surrogacy, Cloning, Assisted Reproduction by Mayanot
I'm thrilled today to welcome new friend, Albertina Antognini and old (by which I mean long-time) friend, Susan Appleton. Albertina Antognini is the James E. Rogers Professor of Law at the University of Arizona where she teaches Family Law, Property, Trusts & Estates, and a seminar surveying different legal regimes that shape the contemporary American family. Professor Antognini's work examines the ways that legal rules actively regulate, and in the process define, families. Her research is centrally preoccupied with considering how categories that may appear “natural” are in fact products of law, with the aim of opening them up to a more rigorous critique.Susan Appleton is the Lemma Barkeloo & Phoebe Couzins Professor of Law at Washington University School of Law. She is a nationally known expert in family law and feminist legal theory. Her research, scholarship, and teaching address reproductive justice, parentage, gender, sexualities, and public assistance for families. They join us today to discuss their recent article, Sexual Agreements, published in the Wash. U. Law Review. UVA Law 3L, Laura Habib, co-hosts this episode. Further ReadingAntognini and Appleton, Sexual Agreements, 99 Wash. U. L. Rev. 1807 (2022)Antognini bio https://law.arizona.edu/person/albertina-antogniniAntognini, Nonmarital Contracts, 73 Stan. L. Rev. 67 (2021)Antognini, Nonmarital Coverture, 99 B.U. L. Rev. 2139 (2019)Appleton bio https://law.wustl.edu/faculty-staff-directory/profile/susan-frelich-appleton/Appleton, Sex Positive Feminism's Values in Search of the Law of Pleasure, in The Oxford Handbook of Feminism and Law in the United States (Deborah L. Brake, Martha Chamallas, & Verna Williams eds., 2023).Appleton, Families Under Construction: Parentage, Adoption, and Assisted Reproduction (with D. Kelly Weisberg) (2021).Krawiec bio https://www.law.virginia.edu/faculty/profile/kdk4q/1181653Krawiec, Gametes: Commodification and The Fertility Industry, in Routledge Handbook of Commodification, Routledge, 278–289 (1 ed. 2023).Krawiec, Markets, repugnance, and externalities, Journal of Institutional Economics 1–12 (2022).Krawiec, No Money Allowed, 2022 University of Chicago Legal Forum 221–240 (2022).
Rabbi Breitowitz- Assisted Reproduction in Halacha by Mayanot
Rabbi Breitowitz- Adoption and Assisted Reproduction in Halacha by Mayanot
Age is just a number, and when it comes to starting a family, that saying rings truer now more than ever. Technology strides and the wider availability of fertility treatment services have opened up the possibility of parenthood later in life. Data show that there is an upward trend in the number of women in Singapore aged 45 and above who give birth each year, with demand for assisted reproduction services rising. Fertility specialist and medical director at Sincere Healthcare Group, Dr Lim Min Yu, shares his perspectives about the risks of In-Vitro Fertilisation (IVF) for older couples, what to consider when embarking on an Assisted Reproduction journey and how best to increase the odds for IVF success. See omnystudio.com/listener for privacy information.
Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro. These podcasts were sponsored by Besins Healthcare.
Moderated by Sue Saville. With speakers: Prof Dr Frank Broekmans, Prof Peter Humaidan, Prof Dr Dominic Stoop, Dr Samuel Santos-Ribeiro. These podcasts were sponsored by Besins Healthcare.
"As a military doctor, she is healing both the physical and emotional wounds of those who have bravely served our country" In our Season-4 Episode-2 we present, Col Nikita Naredi with 24 years of service in the Armed Forces Medical Services and 13 years specialising in Assisted Reproduction. She has dedicated her career to helping couples achieve parenthood through IVF. On our podcast she shares her journey of fulfilling her parents' dreams, her experiences of dealing with different kinds of couples and what compelled her to write her debut novel, “Am I Just A Baby Vending Machine,” where she sheds light on the gory reality of being a woman without a child in a son-preferring society. “Call of Duty” Real Soldiers Real Stories… where we bring real stories from the lives of the soldiers from Indian armed services. Available on Apple , Google, Spotify, Anchor podcasts and Amazon music Podcast Producers: Poonam Joshy Nandita Sankaran Prakrati Agrawal Music credits: Colonel V D Singh Contact us on: podcastcallofduty@gmail.com Follow us on Instagram: https://www.instagram.com/callofdutypodcast Facebook: https://www.facebook.com/callofdutyrsrs
"As a military doctor, she is healing both the physical and emotional wounds of those who have bravely served our country" In our Season-4 Episode-2 we present, Col Nikita Naredi with 24 years of service in the Armed Forces Medical Services and 13 years specialising in Assisted Reproduction. She has dedicated her career to helping couples achieve parenthood through IVF. On our podcast she shares her journey of fulfilling her parents' dreams, her experiences of dealing with different kinds of couples and what compelled her to write her debut novel, “Am I Just A Baby Vending Machine,” where she sheds light on the gory reality of being a woman without a child in a son-preferring society. “Call of Duty” Real Soldiers Real Stories… where we bring real stories from the lives of the soldiers from Indian armed services. Available on Apple , Google, Spotify, Anchor podcasts and Amazon music Podcast Producers: Poonam Joshy Nandita Sankaran Prakrati Agrawal Music credits: Colonel V D Singh Contact us on: podcastcallofduty@gmail.com Follow us on Instagram: https://www.instagram.com/callofdutypodcast Facebook: https://www.facebook.com/callofdutyrsrs
"As a military doctor, she is healing both the physical and emotional wounds of those who have bravely served our country" In our Season-4 Episode-2 we present, Col Nikita Naredi with 24 years of service in the Armed Forces Medical Services and 13 years specializing in Assisted Reproduction. She has dedicated her career to helping couples achieve parenthood through IVF. On our podcast she shares her journey of fulfilling her parents' dreams, her experiences of dealing with different kinds of couples and what compelled her to write her debut novel, “Am I Just A Baby Vending Machine,” where she sheds light on the gory reality of being a woman without a child in a son-preferring society. “Call of Duty” Real Soldiers Real Stories… where we bring real stories from the lives of the soldiers from Indian armed services. Available on Apple , Google, Spotify, Anchor podcasts and Amazon music Podcast Producers: Poonam Joshy Nandita Sankaran Prakrati Agrawal Music credits: Colonel V D Singh Contact us on: podcastcallofduty@gmail.com Follow us on Instagram: https://www.instagram.com/callofdutypodcast Facebook: https://www.facebook.com/callofdutyrsrs
Our first guest of this season, Dr. Karaitiana Tairu, joins us for an insightful discussion on the intersection of AI and the Pacific Islands. Dr. Tairu discusses the intricate balance between preserving cultural heritage and embracing innovation, highlighting the role of AI in creating sustainable solutions tailored to the unique needs of the Pacific Islands. This episode is a must-listen for anyone interested in the convergence of tradition and technology About AI Asia Pacific Institute The AI Asia Pacific Institute (AIAPI) is a global not-for-profit committed to strengthening the Asia-Pacific economies by facilitating the responsible development and adoption of artificial intelligence. The AIAPI serves as an independent catalyst, uniting stakeholders to guide AI's responsible development through interdisciplinary research, awareness raising, international collaboration, and policy advisory activities. About Dr Karaitiana Taiuru Dr Taiuru is a leading authority and a highly accomplished visionary Māori technology ethicist specialising in Māori rights with AI, Māori Data Sovereignty and Governance with emerging digital technologies and biological sciences. He brings extensive expertise in mātauranga, tikanga Māori, te Tiriti and advocacy for digital Māori rights and a profound understanding of the intersection between Māori knowledge and emerging technologies. A professional director with membership with Institute of Directors, with roles including membership and Kahui Māori advisor of the New Zealand AI Forum, member and tangata whenua governor of the AI Researchers Association, invited member of the Expert panel on AI and healthcare for the Office of the Prime Minister's Chief Scientific Advisor, a legislated expert member of the Intellectual Property Office (IPONZ) Trade Marks Advisory Committee and Ministry of Health Tikanga Expert on Assisted Reproduction, as well as many other governance appointments.
In this episode of JCO Article Insights, Dr. Giselle de Souza Carvalho interviews Dr. Hatem Azim and Dr. Ann partridge on their JCO article “Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy,” TRANSCRIPT Giselle Carvalho: Welcome to the JCO Article Insights episode for the August issue of the Journal of Clinical Oncology. This is Giselle Carvalho, your host. I'm a Medical Oncologist in Brazil focusing on breast cancer and melanoma skin cancers, and one of the ASCO editorial fellows at JCO this year. Today, I will have the opportunity to interview Dr. Hatem Azim and Dr. Ann Partridge, two of the authors of the POSITIVE trial. We will be discussing their trial on “Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy,” which was published in May this year. Hello, Dr. Azim and Dr. Partridge. Welcome to our podcast. Dr. Ann Partridge: Hi. Thanks. Dr. Hatem Azim: Hello. Giselle Carvalho: So, beginning with our interview for breast cancer survivors, in addition to the treatment itself, aging is one of the major contributors to infertility. The optimal duration of adjuvant endocrine therapy in patients with hormone positive early breast cancer ranges from five to ten years, depending on patient and tumor characteristics. This time interval can be critical for women who wish to attempt pregnancy. One of the main concerns in daily breast cancer oncology practice is whether breast cancer recurrence rates are increased either by temporary interruption of endocrine therapy for pregnancy or by the use of assisted reproductive technologies. Dr. Azim, what about assisted reproductive technology is worrisome regarding breast cancer outcomes? And how do the POSITIVE study results address the concern about worsening breast cancer outcomes either with assisted reproductive technology or endocrine therapy interruption? Dr. Hatem Azim: So, in the primary analysis of the POSITIVE trial, we tried to address one of these questions, whether temporary interruption with endocrine therapy affects breast cancer outcome. And what we found was that interruption did not appear to have a detrimental impact at the median follow up of 41 months. So in the current manuscript, we addressed the second question, whether assisted production of fertility preservation has an impact as well on breast cancer outcome. And we did not find any worsening of outcomes in patients who underwent these procedures compared to those who had a spontaneous pregnancy. Of course, we have relatively short follow up, but at least the outcomes at the median follow up of around 3 to 4 years appears to be reassuring. Giselle Carvalho: I see. Thank you. These are really important outcomes regarding premenopausal patients. So, moving on, results from your study show that after 24 months, 80% of women under 35 years old had at least one successful pregnancy, while the same was true for 50% of women aged 40 to 42. These results are particularly impressive considering that over 60% of women over 35 had undergone chemotherapy. Dr. Partridge, other than age, what factors did you find were associated with a successful pregnancy? Dr. Ann Partridge: Yeah. The biggest factor, other than age, that was associated with successful live birth pregnancy was use of assisted reproductive technologies. So either having gone through IVF prior to diagnosis and banking eggs or embryos prior to diagnosis and then using them during the study, for undergoing stimulation of the ovaries during the study and then using it during the study. And that's what we also looked at in this most recent analysis of the initial POSITIVE data. Giselle Carvalho: I see. Thank you. The group of patients who underwent embryo oocyte cryopreservation at diagnosis were more likely to be nulliparous and treated with chemotherapy. Presumably these represent the patient group most afraid they will be infertile, as they would be receiving chemotherapy, and most desirous of pregnancy, as they had not yet had any children. Fertility preservation techniques are expensive and not easily available for all patients, particularly in less wealthy countries. Is there any group of your breast cancer patients with a high enough likelihood of pregnancy without assisted reproductive technology that you would not recommend this? Dr. Ann Partridge: Sure. So we are so glad to have assisted reproductive technologies available in many places, but as you know, they're not available everywhere. And even where they're available for some people, it's either inaccessible for a number of reasons or it doesn't feel right emotionally or ethically. And then finally, sometimes people need fairly quick treatment and they just don't have the time, even though we don't think there are long delays. And so we do and are able to know who can get pregnant after standard chemotherapy. Not perfectly, but we can give estimates. And the gestalt is, the younger a woman is, the less likely she is to become amenorrheic and the associated infertile, although it's not a perfect match in terms of amenorrhea being a surrogate. And then there are particular chemotherapy regimens that are more gonadotoxic than others. The more cyclophosphamide, for example, or alkylating agent, the more anthracycline, the higher the likelihood generally of causing at least amenorrhea and likely infertility. The huge caveat there is that for some of our newer therapies, we have no good information about how they might impact on menstrual status, let alone the actual rates of fertility. So we need to collect those data. But certainly, if someone's very young, they're going to get four cycles of TC or they have inflammatory breast cancer, we often take kind of a let the chips fall where they may approach, because they just aren't able to access it and we'll often do something like ovarian suppression through the chemotherapy to help support them and hope that it improves their menstrual functioning in the long run and/or fertility. Giselle Carvalho: Thank you for your insight. So you found that pregnancy incidence over time differed by age group, although incidence of menstrual recovery over time was similar across all age groups, which I conclude that menstrual recovery does not translate into fertility. The addition of gonadotropin releasing hormone analogs to chemotherapy was not associated with time to pregnancy. However, of course, such use was not randomized. Dr. Azim, if assisted reproductive technology is not available to patients for reasons such as socioeconomic factors, would you recommend using GnRH analogs with chemotherapy for the purpose of fertility preservation? Dr. Hatem Azim: Yes. The short answer is yes. Of course, POSITIVE study was not designed to address the question around GnRH analogs, but we do have several randomized studies and meta analyses that have shown clearly that the use of GnRH analogs with chemotherapy reduce the risk of premature ovarian insufficiency. And subgroup analysis of some of these studies have shown a trend towards higher pregnancy rates as well. So, of course, if a patient does not have access to assist reproductive technology, GnRH analogs in combination with chemotherapy represent a very good alternative. Giselle Carvalho: I see. Thank you. Thank you for your response. At enrollment, 93.2% of women on POSITIVE trial had stage 1 or 2 disease and 66% had no negative disease. Therefore, one possible bias is that investigators might have been more comfortable with temporarily interrupting endocrine therapy if the risk of relapse was low. Dr. Partridge, what recommendations would you have for women with stage three hormone receptor positive breast cancer who desire to attempt pregnancy? Dr. Ann Partridge: Yeah, thank you. That's a really good question. It comes up in our tumor boards and discussions about patient care all the time, and I think, as you know, only a small proportion, about 6%, had stage 3 disease. Those patients are at higher risk of recurrence by nature of their stage. Not that all stage 3 are created equal, because, of course, if someone had a complete pathologic response to preoperative therapy and their stage 3 disease at diagnosis went to a PCR, then that person may have even better outcomes in the long run than someone who had postoperative treatment, and we don't know their likelihood even with stage 1 or 2 disease. But someone that you're concerned about their risk of recurrence, they still remain at risk of recurrence. And while we do not think, based on the POSITIVE data and all the data that we've had from retrospective studies and other data sets collected for other reasons, that a pregnancy would worsen their outcome, we certainly don't believe that a pregnancy at this point in time will dramatically improve their outcome or as a treatment for breast cancer. That's when I have a heart to heart conversation with the patient, really acknowledging they still remain at high risk. And most of my colleagues tend to want the patient to get more endocrine therapy into their system before they take a break. We've kind of discussed this, and we want someone to get more like at least three to five years. That may be a little bit paternalistic, because, as we know, taking the break for people with a little lower risk didn't seem to worsen outcomes. Maybe it's fine. I don't know that a break at five years is any better than a break at two years. I don't know. Hatem, how do you handle this in your practice? Dr. Hatem Azim: Well, I completely agree with you, Ann. I mean, it's very much decided on a patient by patient basis. The level of uncertainty that some patients accept to take is not necessarily like others. And sometimes we as physicians, we adopt this. I agree with this paternalistic approach. Nevertheless, it's very important for the patient who is 32, is not necessarily counseled like the patient who's 39, and her acceptance and the feasibility of waiting a bit longer as well in order to attempt pregnancy - the success of pregnancy afterwards is not necessarily the same. So I'm not sure we could adapt a one size fits all approach here. And I do not necessarily tend to factor much the elements around the stage. I think my point to patients is usually, well, you do have give and take this amount of risk of relapse, for example, and whether we accept to take such, what we could refer to as relatively unconventional approach of temporary interrupting endocrine therapy, and when we are comfortable to go ahead with this journey, depending on the feasibility of getting pregnant afterwards as well. So, yeah, I completely agree. It's very customized, based on and tailored according to the patients' situation. Giselle Carvalho: Thank you. I really appreciate your response to this. So, moving forward, tamoxifen alone was the most commonly prescribed endocrine therapy, followed by tamoxifen plus ovarian function suppression. The latter was preferred over aromatase inhibitors ovarian function suppression in the selected population. Endocrine therapy prescription changed in the second half of the recruitment period after July 2017 across all continents, likely due to the results of the SOFT and TEXT trials. It demonstrated absolute improvements in all disease outcomes by escalating endocrine therapy, which was more clinically meaningful in patients with high risk disease. Dr. Azim, how do you imagine this change could impact positive outcomes? Dr. Hatem Azim: Honestly, I'm not necessarily sure that it impacts significantly the way you interpret the data and the way we counsel our patients. So, in our study, some 50% of patients received GnRH analogs and around 15% received AI. And most of the patients, I would say, were recruited in the second half of the study after we had the results from, for example, SOFT and TEXT. Furthermore, as we alluded to earlier, we had 60% of patients who received chemo. So most of our patients had a stage 1 and 2 disease in which you would argue that the absolute difference between the different hormonal therapy options is not necessarily massive. Whether or not this would impact much, I'm not sure. I think the main counseling recommendations would apply, that patients who receive endocrine therapy would be asked to interrupt it for at least three months and then they attempt pregnancy afterwards. I don't know what you think, Anne, but I'm not sure that if we have more patients, and this is pretty much the case now, we have more patients treated with AI. I tend to do this a lot, especially if I'm thinking of interrupting, so I think I'm giving them maybe the best option first. I'm not sure this is necessarily, I mean, affecting me much, while interpreting that it does not appear that temporary interruption on the short term has an impact. Dr. Ann Partridge: I completely agree with your strategy. Depending on the patient and their tolerance, if they have enough risk to warrant ovarian suppression with AI or tamoxifen, of course I recommend that. And yet, at the same time, I agree with you in this group that was in POSITIVE, I think the groups are relatively low enough risk. Although 40% had no positive disease, the majority got chemo, so they weren't that low risk. And so I think over time, these kinds of patients are more and more going to get ovarian suppression. I'm doing that more in my practice as tolerated. And I hope that all that means is that their breast cancer outcomes will be better independent of a pregnancy. Giselle Carvalho: And on the topic of women with higher risk disease, CDK4/6 inhibitors are now used in the high risk adjuvant setting. How do you envision this impacting fertility? Dr. Hatem Azim: Well, this is a very good question. Of course, this is something, this is an area of research that we have to address. Some analysis from some of the adjuvant studies, for example, the PENELOPE-B, I think they reported on some of the results of their study in which they were evaluating palbociclib in the adjuvant setting and did not appear that there was significant differences in terms of the level of estradiol levels and FSH and anti-Müllerian hormone, for example. I think these were the parameters that were evaluated in this study. So, of course, more information. Of course, palb is not the CDK4/6 inhibitor approved in the adjuvant setting. So we need more information as well about the other CDK4/6 inhibitors and longer follow-up. In my view from a counseling perspective, I think maybe you would have a certain level of uncertainty regarding whether or not this could have a mental impact on fertility. But the concept as well of possibly proposing a temporary interruption as we adopted in POSITIVE, would still apply. These patients would be treated as well, often, because if they are receiving CDK4/6 inhibitors in the adjuvant setting, it means that they have a high stage disease, so often they will be treated as well with GnRH analogs. I would counsel them pretty much the same, acknowledging a certain level of uncertainty regarding the data we have today on CDK4/6 inhibitors. Dr. Ann Partridge: Yeah, if they got a full course, they would generally be further out than many people on POSITIVE, because we treat with, for example, the abemaciclib for two years and then you want to wash out and things like that. In POSITIVE, the average was two years. And so you'd expect people of higher risk to be a little further out, which I think would make everybody a little more comfortable too, because someone who's very high risk, you'd worry about very early bad recurrence, too. Giselle Carvalho: Yeah. Thank you. So, Dr. Partridge, regarding adherence to endocrine therapy resumption after the two year break, what was the percentage of patients who resumed treatment and which strategies would you suggest to increase adherence in this case? Dr. Ann Partridge: That's a really great question. In the study, it was well over 70%, which is actually higher than you see in the general population of breast cancer survivors, especially young women. So in some cases, and I can tell you anecdotally, I experienced in my clinic that patients were more likely to start and take their endocrine therapy when they had the promise of the POSITIVE trial, to take a break to have a baby, because some of them don't want to start it, let alone stay on it, if they're told they have to take a full five to ten years. So it actually promoted adherence, ironically. And then for the people who got back on in the real world, the data suggests that by four years, somewhere close to half to 30% to half are no longer taking it. And so in POSITIVE it was, I think, 74% got back on, and that was only at the time point cut off when we did the initial primary data report. And of course more people will have gone back on because some people were still having babies and in the middle of things. And so I think that it's not as much of an issue with POSITIVE. In part, these are very compliant people, right? They're participating in a clinical trial to share the data with the rest of the world. They could have gotten pregnant on their own and they want to do it with their doctors. And so I think this is a little bit of a different group, but it was very reassuring to see that most people got on hormonal therapy after their interruption. Giselle Carvalho: And recurrence of hormone receptor positive breast cancer may occur late. How long do you plan to follow patients enrolled in the POSITIVE trial? Dr. Ann Partridge: So our plan is to follow them for at least 10 years. And it's interesting because we're starting to get close to that. We started enrollment in 2015, so I saw someone earlier this week who will have her 10 year mark next year because she got on in 2015. And that's very exciting. Obviously, it would be great to follow them even longer because ER positive breast cancer can recur many years later. But I do think that we feel as though at least 10 years will give us a good, very evidence-based feeling about the safety. Giselle Carvalho: Thank you. Thanks for sharing. With enrollment occurring at 116 institutions in 20 countries across four continents, this representation of different races and ethnicities provides strength to support this recommendation for this group of patients worldwide. Dr. Azim, what are your hopes for future analysis from this study and what future research in the area are you planning or would like to see performed? Dr. Hatem Azim: So Ann mentioned, of course, it would be crucial to conduct the long term follow up of these patients, and provide more reassuring evidence on the safety of this approach of adjuvant endocrine therapy. So this is something we're really looking forward to. Other analysis that we are working on is the breastfeeding analysis. So looking at patients who underwent breastfeeding and how far the feasibility of this approach, obviously, but how far as well this had an impact on their breast cancer outcome. So this is something that hopefully we are going to report on soon, expected end of this year. As well, we are working on evaluating, we had a large translation research program within POSITIVE, addressing several questions, including the evolution of ovarian function parameters over time and the ovarian reserve. Also, we are working on reporting on this information. We hope that this could happen maybe in the coming year. Giselle Carvalho: Great. And finally, what advice do you give young women in your clinic who have been diagnosed with early stage hormone positive breast cancer and who are hoping to attempt pregnancy. Dr. Hatem Azim: We address these kinds of questions relatively early in their treatments and often they are very much concerned about their chance of future fertility. Usually early on, for example, before going for chemo and so on, I just share the information that this is something that we certainly could discuss and certainly there are the possibility that we could consider in the future that it's not a ‘no go' at least. And definitely it's something that we could work on once treatment is completed and recover from the adverse events of therapy. And because throughout the journey of treatments as well, women's wishes evolve over time and their perception of their pregnancy project as well evolve and change over time. So I think it's important to acknowledge, in my view, it's very important to acknowledge that this is feasible, this is possible, and because this as well provides an important psychological boost for them. And then as the patient comes over for their follow up after therapy and so on, start understanding, getting a little bit deeper into these kind of questions regarding feasibility, timing. If they are ER positive, then if it's okay to interrupt, not to interrupt, to explain a bit better and to consider a bit better regarding what kind of risk we're talking about. Articulating better, what do we mean by risk? So that sometimes you have a patient that is willing to accept a 10% risk, although others 1% risk for them represent a major threat. Also, it matters nulliparous versus a patient who already has two or three kids. So I think I tend to go a bit more granular in this kind of information as patients are out of chemo and on hormonal therapy and start addressing these matters. But I think it's important early on to share the information that nowadays we do have sufficient information not to discourage women who would like to have a pregnancy in the future. Giselle Carvalho: Thank you. Thank you. Dr. Partridge, would you like to add some final comments on this? Dr. Ann Partridge: Yeah, I think this is just such an important issue for our young breast cancer survivors and cancer survivors diagnosed at a young age, regardless of the type of cancer. So I think paying attention to this at diagnosis and through their survivorship is critical, both for their thriving in survivorship as well as for their long term health and cancer outcomes. Getting back to that adherence issue, people, if they're unhappy, won't do all the right things for themselves, sometimes medically and emotionally. And we know that infertility can be associated with long term distress for patients with and without cancer. So we need to pay attention to this and I'm really happy that ASCO is doing a podcast on this and I'm really happy that JCO is doing a podcast on this. Giselle Carvalho: Thank you. I really would like to thank you both, Dr. Azim and Dr. Partridge for attending this interview. This is Giselle Carvalho. Thank you for listening to JCO Article Insights. Don't forget to give us a rating or review and be sure to subscribe so you never miss an episode. You can find all ASCO shows asco.org/podcast. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity or therapy should not be construed as an ASCO endorsement. Dr. Azim Employment Company name: Pierre Fabre, EMERGENCE THERAPEUTICS Stock and Other Ownership Interests Company name: Innate Pharma, Diaacurate Travel, Accommodations, Expenses Company name: Novartis Dr. Partridge Research Funding Company name: Novartis Patents, Royalties, Other Intellectual Property Company name: UpToDate
On July 12th, 1984, the first baby was born through assisted reproduction in Barcelona and all of Spain, but the path to motherhood is not always as linear and easy as it is portrayed. Fertility treatment is becoming more and more common throughout the world, and in Spain, one in every ten children in the Spanish state is born thanks to this technology. This is due in particular to three factors: increasing infertility rates, a higher age for having a first child, and the access to reproductive assistance for single parents and queer couples. But despite all of this, there is still a lot of stigma, secrecy, and sometimes shame associated with this way of having children. On this week's podcast, Cillian Shields and Lea Beliaeva Bander talk to Paula, Montserrat, Marta, and Violeta, four women who have all undergone assisted reproduction in Catalonia, about the ups and downs of fertility treatment, breaking stigmas, creating new family structures and much more. The Catalan phrase of the week is “A poc a poc i amb bona lletra” which means that things have to be done with calm and patience to work out Get in touch with the podcast team: fillingthesink@acn.cat
Forty years ago, on July 12th, 1984, the first baby was born through assisted reproduction in Barcelona and in all of Spain. At the time, the news of a couple seeking help to conceive at the Barcelona Dexeus private hospital made headlines everywhere. But a lot has happened since then: in 2006, assisted reproduction became available for free through the public health system throughout Spain. Later, in 2016, a change in the law also made it possible for single mothers and queer couples to avail of the service, and by 2023, thanks to the so-called Spanish “trans law,” trans people had also gained access. Today, the Spanish government estimates that around 10% of all babies born in Spain are the result of assisted reproduction, and that number is growing every year. Cillian Shields joins Lea Beliaeva Bander to chat about the system of assisted reproduction in Catalonia, how it has evolved over time, what the different types of treatment mean, and why it brings people from all over the world to Catalonia. We will also talk to Anna Veiga, the pioneering Catalan doctor and biologist who led the first IVF birth in all of Spain, and Dr. Federica Moffa, the medical director of the private fertility clinic Fertilab, about reproductive tourism. For the first time in the history of Filling the Sink, this episode will be the first of two dedicated to a single topic, so remember to stay tuned for the next episode, where we talk to four women about their experiences with assisted reproduction in Catalonia. This week's Catalan phrase is “donar a llum”, which literally means “to give to light” and is the Catalan way of saying “to give birth.” Get in touch with the podcast team: fillingthesink@acn.cat
The passing of the Assisted Reproduction Bill 2022 in the Dáil on Wednesday has been welcomed by many families and couples nationwide. However, for same sex parents that have used surrogacy, the Bill continues to ignore some of the main wishes they sought in previous drafts. Joining Andrea to discuss are Ranae Von Meding, CEO of Equality for Children and Seamus Kearney Martone, Chairperson of Irish Gay Dads.
DOI: 10.13056/acamh.27597 In this Papers Podcast, Maria Palma and Associate Professor Alice Goisis discuss their co-authored JCPP paper ‘Medically assisted reproduction and mental health in adolescence: evidence from the UK Millennium Cohort Study' (https://doi.org/10.1111/jcpp.13877). There is an overview of the paper, methodology, key findings, and implications for practice. Discussion points include: What the UK Millennium Cohort Study is. The differences in parental reports on adolescent mental health between MAR (medically assisted reproduction) adolescents and naturally conceived adolescents. The differences between adolescent self-reports and parental reports on adolescent mental health. The association between MAR conception and mental health outcomes in adolescents. Implications for clinical practice and researchers. In this series, we speak to authors of papers published in one of ACAMH's three journals. These are The Journal of Child Psychology and Psychiatry (JCPP); The Child and Adolescent Mental Health (CAMH) journal; and JCPP Advances. #ListenLearnLike
Welcome back to another engaging episode of "Taco Bout Fertility Tuesday" with your host, Dr. Mark Amols. This week, we delve into the complex and often misunderstood stages of IVF, focusing on the journey from egg retrieval to the development of blastocysts. It's a numbers game where the stats don't always add up as expected, and understanding these dynamics can be crucial for anyone embarking on or considering IVF.In this detailed exploration, Dr. Amols explains the attrition rates at each critical phase of IVF: from the number of eggs retrieved to those that fertilize, and further to those that reach the pivotal blastocyst stage. Why do some eggs fail to fertilize, and what happens to those that do but don't progress? These questions and more are addressed with clarity and insight.Listeners will gain a realistic perspective of IVF, tempered with both scientific data and personal stories that illustrate the emotional and physical journey involved. Dr. Amols uses compelling analogies, like a disappointing meal at a favorite restaurant, to highlight how expectations can differ vastly from reality. This approach not only simplifies complex biological processes but also connects emotionally with listeners' own experiences.Whether you're knee-deep in fertility treatments or simply curious about how IVF works behind the scenes, this episode promises to enlighten and inform. Get ready to adjust your expectations, understand the odds, and learn how the quality of eggs and sperm, technological interventions, and personal health all play integral roles in the success of IVF treatments.So grab your favorite taco and settle in for a session that demystifies the numbers and enriches your understanding of the IVF process. It's more than just science; it's about setting the stage for future miracles in fertility treatments.Thanks for tuning in to another episode of 'Taco Bout Fertility Tuesday' with Dr. Mark Amols. If you found this episode insightful, please share it with friends and family who might benefit from our discussion. Remember, your feedback is invaluable to us – leave us a review on Apple Podcasts, Spotify, or your preferred listening platform. Stay connected with us for updates and fertility tips – follow us on Facebook. For more resources and information, visit our website at www.NewDirectionFertility.com. Have a question or a topic you'd like us to cover? We'd love to hear from you! Reach out to us at TBFT@NewDirectionFertility.com. Join us next Tuesday for more discussions on fertility, where we blend medical expertise with a touch of humor to make complex topics accessible and engaging. Until then, keep the conversation going and remember: understanding your fertility is a journey we're on together.
In this episode of The Worst Girl Gang Ever, hosts Bex Gunn & Laura Buckingham talk to community member Keri Croft about her journey with infertility, child loss, and surrogacy. Keri opens up about her long struggle to start a family, facing multiple miscarriages and fertility treatments over many years. She shares her experience of finally finding success through surrogacy and welcoming her daughter. The episode also covers Keri's emotional journey, coping mechanisms, and the challenges of navigating surrogacy independently. Keri's story sheds light on the importance of normalising discussions around assisted reproduction and providing ongoing support for those dealing with loss. In this episode you will hear: Keri's personal story of infertility and loss spanning over a decade How she coped emotionally through her struggles and found support The process of navigating surrogacy independently Her experience of anxiety during her surrogate's pregnancy Advice on normalising conversations around assisted reproduction The importance of checking in on others long-term after loss Get in touch with Keri on keri@thekericroftshow.com or DM her on Insta https://www.instagram.com/thekericroftshow/ The Warriorship is a membership to help you navigate life after baby loss. It covers every stage of the recovery pathway, and provides support, advice, and a range of emotional tools to help you through this difficult time. This is more than a support group. For more information and to join The Warriorship go to: https://theworstgirlgangever.co.uk/warriorship/ The Worst Girl Gang Ever is a real, honest emotive podcast that covers the heartbreaking subject of miscarriage, infertility and baby loss, expect honest conversations about unspoken experiences. Hosted by TWGGE founders Bex Gunn and Laura Buckingham, this show is a chance to break the silence and really open up the dialogue around the topic of miscarriage and pregnancy loss. No more shame, no more taboo - let's ditch that for our children; the ones that will come, the ones that are and the ones that never came to be. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this intriguing episode of "Taco Bout Fertility Tuesday," Dr. Mark Amols takes us on a deep dive into the world of rescue ICSI (Intracytoplasmic Sperm Injection). With a blend of medical expertise and relatable analogies, Dr. Amols unfolds the complexities behind this emergency fertility procedure used in unexpected cases of failed fertilization. Discover why rescue ICSI isn't just a simple backup plan, but a nuanced decision with varying success rates compared to planned ICSI. This episode illuminates the crucial differences, providing clarity and hope for those navigating the challenging journey of IVF. Tune in to understand why in the delicate dance of creating life, timing and technique are everything!Thanks for tuning in to another episode of 'Taco Bout Fertility Tuesday' with Dr. Mark Amols. If you found this episode insightful, please share it with friends and family who might benefit from our discussion. Remember, your feedback is invaluable to us – leave us a review on Apple Podcasts, Spotify, or your preferred listening platform. Stay connected with us for updates and fertility tips – follow us on Facebook. For more resources and information, visit our website at www.NewDirectionFertility.com. Have a question or a topic you'd like us to cover? We'd love to hear from you! Reach out to us at TBFT@NewDirectionFertility.com. Join us next Tuesday for more discussions on fertility, where we blend medical expertise with a touch of humor to make complex topics accessible and engaging. Until then, keep the conversation going and remember: understanding your fertility is a journey we're on together.
Refute the Top 5 Gay Myths with this free eBook: https://ruthinstitute.org/top-5-myths Get the full interview by joining us for exclusive, uncensored content on Locals: https://theruthinstitute.locals.com/post/5275567/life-giving-wounds-from-divorce-dr-dan-and-bethany-meola-on-the-dr-j-show-ep-223 Dr. Daniel Meola is an adult child of divorce who earned his Ph.D. in Theology of Marriage and Family from the Pontifical John Paul II Institute for Studies on Marriage and Family in Washington, D.C. He and his wife Bethany has been leading retreats and support groups for adult children of divorce or separation since 2015 in the Archdiocese of Washington, and in 2018 he founded Life-Giving Wounds (https://www.lifegivingwounds.org/) to spread the retreat, support groups, and other ministry to adult children of divorce or separation around the country. Bethany Meola is a stay-at-home mom with a master of theological studies degree from the Pontifical John Paul II Institute for Studies on Marriage and Family in Washington, D.C. She and Dan met there and married in 2011. Bethany served the U.S. Conference of Catholic Bishops for seven years in the Secretariat of Laity, Marriage, Family Life and Youth. Among other tasks, she managed the website For Your Marriage, and researched and wrote on various topics related to marriage and family. In 2017, Dan and Bethany welcomed their daughter Zelie-Louise through the gift of adoption, and Bethany became a stay-at-home mom. And in 2019, Grace joined their family, also through adoption. Bethany assists with many of the behind-the-scenes operations of Life-Giving Wounds. The couple has a new book, “Life Giving Wounds: A Catholic Guide to Healing for Adult Children of Divorce or Separation” (Ignatius Press). Life Giving Wounds website: https://www.lifegivingwounds.org/ Life Giving Wounds new book: https://www.lifegivingwounds.org/book Dr. Dan and Bethany previously on The Dr J Show: https://www.youtube.com/watch?v=FiLl41APX8o Dr. Morse summarizes the issue of children of divorce: https://ruthinstitute.org/ruth-speaks-out/children-of-divorce-suffer-negative-consequences/ Leila Miller's book, Primal Loss: https://ruthinstitute.org/product/primal-loss-the-now-adult-children-of-divorce-speak/ Ruth Institute resources for children of divorce: https://ruthinstitute.org/?s=children+of+divorce The Ruth Institute Survivor Series pamphlet, Children of Divorce: https://ruthinstitute.org/product/children-and-divorce/ The Ruth Institute Survivor Series pamphlet, Children of Same-Sex parents: https://ruthinstitute.org/product/children-and-same-sex-parenting/ The Ruth Institute Survivor Series pamphlet, Children of Assisted Reproduction: https://ruthinstitute.org/product/children-and-donor-conception-and-assisted-reproduction/ This episode of The Dr J Show may also be seen on the following platforms: TheRuthInstitute.Locals.com https://rumble.com/c/TheRuthInstitute https://www.bitchute.com/channel/MXkWgTk4Brwr/ https://odysee.com/@TheRuthInstitute:7 Sign up for our weekly newsletter here: https://ruthinstitute.org/newsletter/ +
In episode 34 of The Road to Wisdom Podcast Chloe & Keshia have a difficult to digest conversation with Kallie Fell about the IVF industry, surrogacy and the ethical dilemmas associated with big fertility. Kallie started her professional career as a scientist in the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center utilizing a Master of Science degree in Animal Sciences with an emphasis on Reproductive Physiology and Molecular Biology from Purdue University. While assisting in the investigation of endometriosis and pre-term birth, Kallie simultaneously pursued a degree in nursing with hopes of working with women as a perinatal nurse. After meeting Jennifer at a conference, Kallie became interested in the work of the Center for Bioethics and Culture and started volunteering with the organization. It is obvious that Kallie is passionate about women's health. She continues to work, as she has for the past 6 years, as a perinatal nurse and has worked with the Centre of Bioethics and Cultural Network since 2018, first as a volunteer writer, then as our staff Research Associate, and now as the Executive Director. In 2021, Kallie co-directed the CBC's newest documentary, Trans Mission: What's the Rush to Reassign Gender? Kallie also hosts the popular podcast Venus Rising and is the Program Director for the Paul Ramsey Institute. In this difficult to fathom episode we deep dive into the moral and ethical complications surrounding assisted reproductive technology including IVF, Surrogacy, egg and sperm donation and the potential for these technologies to advance in the future and how its relating to transhumanism. Loved what you heard in this episode? Your support means the world. Make sure to hit that subscribe button, spread the word with your pals, and drop us a review. By doing so, you're not just tuning in – you're fueling our community's growth and paving the way for more incredible guests to grace our show. As the week rolls by, we're already cooking up more tantalizing content for your hungry ears. Keen to stay in the loop with the latest episode releases? Follow our journey on Instagram at @theroadtowisdom.podcast and catch behind-the-scenes action on our YouTube channel @theroadtowisdompodcast. Don't miss out on a thing – also, snag the freshest updates straight to your inbox by subscribing to our newsletter over at https://www.theroadtowisdompodcast.com/. It's your VIP ticket to all things The Road To Wisdom
In episode 34 of The Road to Wisdom Podcast Chloe & Keshia have a difficult to digest conversation with Kallie Fell about the IVF industry, surrogacy and the ethical dilemmas associated with big fertility. Kallie started her professional career as a scientist in the Department of Obstetrics and Gynecology at Vanderbilt University Medical Center utilizing a Master of Science degree in Animal Sciences with an emphasis on Reproductive Physiology and Molecular Biology from Purdue University. While assisting in the investigation of endometriosis and pre-term birth, Kallie simultaneously pursued a degree in nursing with hopes of working with women as a perinatal nurse. After meeting Jennifer at a conference, Kallie became interested in the work of the Center for Bioethics and Culture and started volunteering with the organization. It is obvious that Kallie is passionate about women's health. She continues to work, as she has for the past 6 years, as a perinatal nurse and has worked with the Centre of Bioethics and Cultural Network since 2018, first as a volunteer writer, then as our staff Research Associate, and now as the Executive Director. In 2021, Kallie co-directed the CBC's newest documentary, Trans Mission: What's the Rush to Reassign Gender? Kallie also hosts the popular podcast Venus Rising and is the Program Director for the Paul Ramsey Institute. In this difficult to fathom episode we deep dive into the moral and ethical complications surrounding assisted reproductive technology including IVF, Surrogacy, egg and sperm donation and the potential for these technologies to advance in the future and how its relating to transhumanism. Loved what you heard in this episode? Your support means the world. Make sure to hit that subscribe button, spread the word with your pals, and drop us a review. By doing so, you're not just tuning in – you're fueling our community's growth and paving the way for more incredible guests to grace our show. As the week rolls by, we're already cooking up more tantalizing content for your hungry ears. Keen to stay in the loop with the latest episode releases? Follow our journey on Instagram at @theroadtowisdom.podcast and catch behind-the-scenes action on our YouTube channel @theroadtowisdompodcast. Don't miss out on a thing – also, snag the freshest updates straight to your inbox by subscribing to our newsletter over at https://www.theroadtowisdompodcast.com/. It's your VIP ticket to all things The Road To Wisdom
In this episode of LifeBeat, we discuss the Michigan legislation we anticipate will see action in 2024. We discuss the Assisted Reproduction and Surrogacy Parentage Act which was passed in the Michigan House before the 2023 session ended in early November. We also mentioned the package of bills that were introduced in the MI Senate and would legalize physician-assisted suicide. We end the episode by briefly discussing how parental consent for abortions could be pro-abortion legislators' next target.
In this enlightening episode of "Taco Bout Fertility Tuesday", we delve deep into the often misunderstood world of egg donation. Join us as we unravel the complexities surrounding the use of donor eggs, a journey that many individuals and couples embark on in the pursuit of starting a family.We kick off the discussion by exploring the intricate process of egg donation, shedding light on the critical decisions that come with choosing between fresh and frozen donor eggs. As we navigate through the labyrinth of options, we provide insights into which route might be the best fit for different situations, helping you make informed decisions.But the journey doesn't stop at choices; we venture further to discuss the potential candidates who might benefit from egg donation, offering guidance on the steps to take if you find yourself needing to walk this path. From understanding the financial implications to grappling with the emotional aspects, we cover it all.One of the pivotal points of this episode is addressing the fears and apprehensions that often accompany the thought of using donor eggs. We tackle these concerns head-on, offering a compassionate perspective to help alleviate anxieties and empower you with the knowledge to move forward confidently.Whether you are considering egg donation yourself or seeking to understand the experiences of others, this episode serves as a comprehensive guide, providing a beacon of hope and a wealth of information to those navigating the fertility landscape.Tune in to this heartfelt and informative episode, where we 'Taco Bout' the realities, the possibilities, and the beautiful potential that egg donation can bring to the fertility journey.
In this episode we talk with Jessica King, an EBB Childbirth Class graduate, about their journey to parenthood and the importance of finding support networks before, during, and after pregnancy. Jessica grew up in Upstate New York and then moved to Boston to get her Master's in architecture. While in Boston, she met her wife and fellow upstate New Yorker, Sarah. They started working on creating their family three years ago, and they welcomed their daughter this past November! Jessica and Sarah are graduates of the Evidence Based Birth Childbirth Class with EBB Instructor, Anna Sutkowski. Their family currently lives in St. Louis with their two dogs. Jessica and her wife, a surgical resident, decided to take the EBB Childbirth Class to ease their anxieties and demystify the process of labor and delivery. In this podcast episode, Jessica opens up about her family's struggles, setbacks, and joy in their journey from assisted reproduction to postpartum. Jessica also shares how she was able to use the skills and knowledge learned in the course to advocate for herself postpartum when she had difficulties with lactation and a postpartum mood disorder. We wrap up this episode by talking about how knowing you are not alone can make all the difference in the world. Trigger Warning: assisted reproduction, ovarian hyperstimulation syndrome (OHSS), pregnancy loss, bleeding in pregnancy, epidurals, preeclampsia, newborn jaundice, and postpartum mood disorders. Resources: Learn more about Anna Sutkoski and her EBB Childbirth Class here For more information and news about Evidence Based Birth®, visit www.ebbirth.com. Find us on: TikTok Instagram Pinterest Ready to get involved? Check out our Professional membership (including scholarship options) here Find an EBB Instructor here Click here to learn more about the Evidence Based Birth® Childbirth Class.
As part of our farewell to The Takeaway, Melissa Harris-Perry sits down with the folks behind the scenes who make the show happen every day. Today, we're highlighting the work of Mary Steffenhagen — an award-winning investigative journalist and producer who joined The Takeaway just over a year ago — by listening back to a few of her favorite segments: • "When Women's Survival is Criminalized" and "Corrections in Ink" • "A Culture of Abuse and Cover-Ups in the Southern Baptist Convention" • "How Trains Left Indelible Tracks on American Culture" • "Music In Their Own Words: Sylvan Esso" • "The Realities of Race in Assisted Reproduction" • "Human Composting is Legal in New York—Now What?" Mary Steffenhagen's original reporting on labor organizing, social activism, and the political movement behind homeschooling has earned awards from the Sidney Hillman Foundation (Hillman Award), the Newswomen's Club of New York (Front Page Award) and multiple national student journalism associations. She has reported for outlets including Teen Vogue, City Limits and Chalkbeat. She was also a Fulbright scholar in the 2022 Berlin Capital Program and previously interned at Salon and Coda Media, where she helped produce a weekly news podcast. She earned a masters' in investigative and audio journalism from the Craig Newmark Graduate School of Journalism at CUNY in 2021. Find her on Twitter @marynotmerry__ and at www.marysteffenhagen.com
As part of our farewell to The Takeaway, Melissa Harris-Perry sits down with the folks behind the scenes who make the show happen every day. Today, we're highlighting the work of Mary Steffenhagen — an award-winning investigative journalist and producer who joined The Takeaway just over a year ago — by listening back to a few of her favorite segments: • "When Women's Survival is Criminalized" and "Corrections in Ink" • "A Culture of Abuse and Cover-Ups in the Southern Baptist Convention" • "How Trains Left Indelible Tracks on American Culture" • "Music In Their Own Words: Sylvan Esso" • "The Realities of Race in Assisted Reproduction" • "Human Composting is Legal in New York—Now What?" Mary Steffenhagen's original reporting on labor organizing, social activism, and the political movement behind homeschooling has earned awards from the Sidney Hillman Foundation (Hillman Award), the Newswomen's Club of New York (Front Page Award) and multiple national student journalism associations. She has reported for outlets including Teen Vogue, City Limits and Chalkbeat. She was also a Fulbright scholar in the 2022 Berlin Capital Program and previously interned at Salon and Coda Media, where she helped produce a weekly news podcast. She earned a masters' in investigative and audio journalism from the Craig Newmark Graduate School of Journalism at CUNY in 2021. Find her on Twitter @marynotmerry__ and at www.marysteffenhagen.com
In this episode we discuss Peyronies disease, a condition faced by about 10% of men. Peyronies disease can cause pain, erectile dysfunction and, for some men, a complete inability to have sex. But what exactly is Peyronies disease and what causes the condition? How do you know if you have it? Does Peyronies disease always require treatment? What are the treatment options and how well do they work? To answer these questions and many more, we turned to a true expert. Dr. Darshan Patel is an assistant professor of Urology at the University of California San Diego School of Medicine. He completed his medical training at the Drexel University College of Medicine in Philadelphia, Pennsylvania and then completed a residency in urologic surgery, a clinical research fellowship in Reconstructive Urology, and a fellowship in Men's Health, Andrology, and Microsurgery at the University of Utah. Dr. Patel has authored over 100 publications and textbook chapters. His research has appeared in journals such as Fertility and Sterility, Journal of Assisted Reproduction and Genetics, Urology, Journal of Urology, World Journal of Urology, and the British Journal of Urology.#peyronies #peyroniesdisease #erectiledysfunction #sex
The Sumatran rhinoceros is the smallest and most ancient rhino species and is the only surviving species with hair. It is critically endangered. Because of poaching and habitat destruction, there are fewer than 50 of them left in the wild and those are scattered in the rainforests of Sumatra and the Indonesian part of Borneo. […]
In this episode, we are talking with Scarlett Lynsky (she/her) from Hatchings Doula all about her experiences as an Evidence Based Birth® Instructor and two-time gestational surrogate. Scarlett Lynsky was born, raised, and practices as a doula and childbirth educator in Portland, Oregon. Fascinated by childbirth from an early age, and inspired by Grantly Dick-Read's Childbirth Without Fear, she decided to become a Childbirth Educator and Doula in 2009. Over the last 13 years, Scarlett has attended over 200 births. She is passionate about informed consent, bodily autonomy and tuning in to each birthing person's needs at any given moment. Scarlett has two children of her own as well as completing two "extra credit births" in the form of gestational surrogacy. She continues to be in awe of the transformative power of birth and the strength and bravery of every birthing person. In this episode, Scarlett shares how she came into birth work and why she chose to pursue two very different but equally beautiful surrogacy journeys. We discuss the nuances of being a surrogate and the importance of open and clear communication between the gestational carrier, the intended parent(s), and their support and care teams. Content Warnings: fertility/infertility, miscarriage, pregnancy loss, bleeding in pregnancy, subchorionic hemorrhage, abortion, pregnancy termination, assisted reproduction, IVF, 3rd party reproduction, gendered language, adoption, maternal mortality, high risk pregnancy, discussion of down syndrome, pregnancy complications related to uterine loss Resources and References: Find out more about Scarlett's EBB Childbirth Class and Doula services on her website here and follow her on Instagram here. Childbirth Without Fear: The Principles and Practice of Natural Childbirth by Grantly Dick-Read (1959), find a copy here Learn about agency Scarlett worked with in Oregon, Northwest Surrogacy Center here. Go to our YouTube channel to see video versions of the episode listed above!! For more information and news about Evidence Based Birth®, visit www.ebbirth.com. Find us on: TikTok Instagram Pinterest Ready to get involved? Check out our Professional membership (including scholarship options) here Find an EBB Instructor here Click here to learn more about the Evidence Based Birth® Childbirth Class.
Stephanie Gray Connors is most known for her riveting pro-life presentation at Google headquarters that went viral in 2017. She tackles tough topics with thoughtfulness, care, and compassion. A seasoned and international speaker, Stephanie is originally from Canada, and began presenting at the age of 18. She has given over 1,000 pro-life presentations over two decades across North America as well as in Scotland, England, Ireland, Austria, Latvia, Guatemala, Mexico, and Costa Rica. She has spoken at many post-secondary institutions such as Yale University, George Washington University, and the University of California, Berkeley. Stephanie has debated abortion advocates such as abortionists in front of medical students at universities. She has debated Princeton philosophy professor Pete Singer, National Coalition of Abortion Providers executive director Ron Fitzsimmons, legal director for NARAL Elizabeth Cavendish, medical director for International Planned Parenthood Federation Dr. Malcolm Potts, and many others. In 2019, Stephanie participated in an historic eight-woman debate on abortion at La Ciudad de las Ideas (CDI) in Puebla, Mexico. Besides speaking on abortion, she also presents on assisted suicide. Stephanie has been a guest on CTV News, CBC News, CBC's The Current, Global News, EWTN, Back to the Bible, Catholic Answers Radio, Relevant Radio, 100 Huntley Street's Listen Up, and the Miracle Channel's Insight. She has been interviewed by ABC-, NBC-, FOX-, and CBS-affiliated television news programs throughout the Midwest of the United States. Stephanie is author of the books Conceived by Science: Thinking Carefully and Compassionately about Infertility and IVF, and, Start with What: 10 Principles for Thinking about Assisted Suicide, and, Love Unleashes Life: Abortion & the Art of Communicating Truth. She holds a Bachelor of Arts in Political Science from UBC in Vancouver, and a Certification, with Distinction, in Health Care Ethics, from the NCBC in Philadelphia. Love Unleashes Life: https://loveunleasheslife.com Stephanie's book CONCEIVED BY SCIENCE: Thinking Carefully and Compassionately About Infertility and IVF: https://www.amazon.com/dp/1736454420 Catholic instruction of the dignity of the human person: https://www.vatican.va/roman_curia/congregations/cfaith/documents/rc_con_cfaith_doc_20081208_dignitas-personae_en.html More about Stephanie's books: https://loveunleasheslife.com/love-unleashes-life/ Stephanie's talk "Abortion: From Controversy to Civility": www.YouTube.com/watch?v=DzzfSq2DEc4 Stephanie's talk "The Case Against IVF": https://www.catholic.com/audio/cot/the-case-against-ivf-with-stephanie-gray-connors Katy Faust of Them Before Us on The Dr J Show: www.YouTube.com/watch?v=HKNryQtj5EM and www.YouTube.com/watch?v=_xYrRDC1mpo RI pamphlet "Children and Donor Conception and Assisted Reproduction": https://ruthinstitute.org/product/children-and-donor-conception-and-assisted-reproduction/ Dr. Morse's article on Dave Rubin "adopting" a child: https://ruthinstitute.org/ruth-speaks-out/dave-rubin-and-the-death-of-secular-conservatism/ Dr. Thomas Hilgers on The Dr J Show: www.YouTube.com/watch?v=5WDOK-UjKw0 Sign up for our weekly newsletter here: https://ruthinstitute.org/newsletter This Dr J Show is also on the following platforms: www.YouTube.com/watch?v=UoDVr6CndD0 https://www.bitchute.com/video/PuKn1mhAyPGd/ https://rumble.com/v1e1vx7-is-in-vitro-fertilization-ethical-stephanie-gray-connors-on-the-dr-j-show-e.html https://odysee.com/@TheRuthInstitute:7/143gray-connors-SMALL-FILE:3 Be sure to subscribe, and check out ALL the Dr J Shows! +
Assisted reproduction clinics have seen a sharp rise in the number of Black folks seeking their services during the pandemic. But many face a barrier even before pregnancy that they weren't even aware of: a shortage of Black sperm donors. For many, having a Black donor is a primary concern in building families that reflect their cultures and identities. And while the best current scientific evidence indicates there's no genetic basis for the idea of race, that doesn't mean it doesn't matter to people when they are building their families — especially when they're using assisted reproductive technologies. We speak with Dr. Camisha Russell, associate professor of philosophy at the University of Oregon and author of the book “The Assisted Reproduction of Race.” We're also joined by Regina Townsend, founder of The Broken Brown Egg, an infertility support community for Black individuals and families. And, we hear from a Black man who donated sperm on what creating a Black family means to him. For full transcript, see above.
Assisted reproduction clinics have seen a sharp rise in the number of Black folks seeking their services during the pandemic. But many face a barrier even before pregnancy that they weren't even aware of: a shortage of Black sperm donors. For many, having a Black donor is a primary concern in building families that reflect their cultures and identities. And while the best current scientific evidence indicates there's no genetic basis for the idea of race, that doesn't mean it doesn't matter to people when they are building their families — especially when they're using assisted reproductive technologies. We speak with Dr. Camisha Russell, associate professor of philosophy at the University of Oregon and author of the book “The Assisted Reproduction of Race.” We're also joined by Regina Townsend, founder of The Broken Brown Egg, an infertility support community for Black individuals and families. And, we hear from a Black man who donated sperm on what creating a Black family means to him. For full transcript, see above.
Did you know that men are just as affected by infertility as women? Yet, society tends to focus on female infertility more commonly. Because of the lack of discussion, many men wait too long to seek help for fertility issues. Dr. Scott Lundy, a urologist at the Cleveland Clinic, discusses different causes of male infertility and common treatment options men may not know about. Learn more: https://radiohealthjournal.org/why-we-need-to-have-better-discussions-around-male-infertility/
In episode #106 Troy shares his expertise as the founder of a pharmaceutical company and his personal story experiencing infertility with his wife. Troy has always been interested in health research, and he discovered the MTHFR mutation issue in 2010. He began a deep dive into this issue as it relates to fertility and pregnancy, and he was amazed by how many people are affected. With the right tests, it was discovered that his wife had the MTHFR mutation. Proper supplementation allowed her to get pregnant and they were able to have their second child. We discuss the difference between folic acid and folate, how the MTHFR mutation affects fertility and pregnancy, and how proper folate supplementation can make a big difference. References are listed below, and Troy is offering a discount code for your first bottle of prenatal vitamins from his company, Centurion Labs. Topics Discussed: infertility, folic acid, folate, MTHFR mutation, prenatal vitamins CONNECT WITH TROY - centurionlabs.com Use coupon code HOPE for 67% off your first bottle of prenatal vitamins! MISCARRIAGE HOPE DESK RESOURCES- Miscarriage Hope Desk aims to help women struggling miscarriage, pregnancy loss and recurrent miscarriages (RPL), by providing the following resources- - Library of Articles, found here- https://miscarriagehopedesk.com/library/understanding-why/ - Instagram Community- https://instagram.com/miscarriagehopedesk - Facebook Community- https://www.facebook.com/groups/1617075958466247/ - Free Miscarriage Lab Checklist- https://miscarriagehopedesk.com/labs - Free Weekly Newsletter- http://miscarriagehopedesk.com/newsletter FREE MEAL PLANS Do you need help getting healthy, tasty meals on the table? Check out our sponsor Prep Dish, PrepDish.com/mhd to get 2 weeks FREE! SHOW NOTES- https://miscarriagehopedesk.com/podcast/ Get a FREE Miscarriage Lab Testing Checklist- MiscarriageHopeDesk.com/labs REFERENCES: Scaglione, F., Panzavolta, G., Folate, Folic Acid and 5-methyltetrahydrofolate are not the same thing, Xenobiotica. Feb. 2014 Servy, Edouard, et.al., MTHFR isoform carriers. 5-MTHF (5-methyl tetrahydrofolate) vs. folic acid: a key to pregnancy outcome: a case series. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-018-1225-2 Greenberg, J. Multivitamin Supplementation During Pregnancy: Emphasis on Folic Acid and L-Methylfolate. Reviews in Obstetrics & Gynecology. 2011, Vol. 4 pg 126-127. D'Elia, PQ., et.al., MTHFR polymorphisms C677T and A1298C and associations with IVF outcomes in Brazilian women. Reproductive Biomedicine Online 2014 Jun;28(6):733-8. doi: 10.1016/j.rbmo.2014.02.005. Naqvi, H., et.al., Role of 677C® T polymorphisms a single substitution in methylenetetrahydrofolate reductase (MTHFR) gene in North Indian infertile men. Molecular Biology Reports. Feb. 2014; 41(2):573-9. Mfady, DS, et. al., Associations of variants in MTHFR and MTRR genes with male infertility in the Jordanian population. Gene. 2014 Feb 15;536(1):40-4. doi: 10.1016/j.gene.2013.12.001. Gava, MM, et.al., Polymorphisms in folate-related enzyme genes in idiopathic infertile Brazilian men. Reproductive Sciences 2011 Dec;18(12):1267-72. doi: 10.1177/1933719111411729. Shen, O., et.al., Association of the Methylenetetrahydrofolate Reductase Gene A1298C Polymorphism with Male Infertility: A Meta-Analysis Updated Estimates of Neural Tube Defects Prevented by Mandatory Folic Acid Fortification, Centers for Disease Control (CDC): Morbidity and Mortality Weekly Report (MMWR), January 16, 2015. McGowan, E., et.al., Association Between Folate Metabolites and the Development of Food Allergy in Children. Journal of Allergy and Clinical Immunology. January 2020; 8(1):132-140. McStay, Catrina, Maternal Folic Acid Supplementation during Pregnancy and Childhood Allergic Disease Outcomes: A Question of Timing. Nutrients. 2017 February. Wang, T., et. al., Is Folate Status a Risk Factor for Asthma or Other Allergic Diseases?, Allergy, Asthma & Immunology Research. 2015 November; 7(6): 538-546. Whitrow, Melissa, et. al., Effect of Supplementatl Folic Acid in Pregnancy on Childhood Asthma: A Prospective Birth Cohort Study. American Journal of Epidemiology. October 2009. Vol. 170, No. 12.
A new MP3 sermon from Harvest Reformed Presbyterian Church is now available on SermonAudio with the following details: Title: Contraception & Assisted Reproduction: Right or Wrong? Subtitle: Exodus: Who Is the LORD? Speaker: Caleb Nelson Broadcaster: Harvest Reformed Presbyterian Church Event: Sunday School Date: 8/28/2022 Bible: Exodus 20:14 Length: 41 min.
Troy Duell has been in the pharmaceutical industry for over 20 years. He realized pharmaceutical companies were prioritizing profits over health and products that were expensive, ineffective, and often harmful. He felt the pull to develop a company that put people and their health over profits. Through his personal story and passion for helping others, he started to dive into what was really in our vitamins and how it affects our health. In this episode he addresses folic acid verses folate, the MTHFR gene defect and vital nutrition for fertility and pregnancy. Check out Bump DHA https://centurionlabs.com/about-bump/ Code Mama for discount off first bottle. Connect: https://www.instagram.com/bumpdha/ https://centurionlabs.com/ Connect with Elizabeth: https://www.elizabethjoy.co/ IG: https://www.instagram.com/miraculousmamas/ https://www.truebill.com/mamas https://www.functionofbeauty.com/mamas for 25% off first order https://www.coterie.com/ Promo code Mamas for 20% off and free shipping Resources: 1. American Academy of Allergy, Asthma & Immunology. (2018). Folic Acid Exposure in Utero is Associated with Development of Food Allergy. The Journal of Allergy and Clinical Immunology, 141(2). (Presented at the 2018 AAAAI/ WAO Joint Congress, Orlando, FL.). 2. Servy, Edouard, et.al., MTHFR isoform carriers. 5-MTHF (5-methyl tetrahydrofolate) vs. folic acid: a key to pregnancy outcome: a case series. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-018-1225-2
Lawyers who specialize in donor-assisted reproduction and adoption dread getting one call in particular from intended parents: Their baby is due in a few days and they're ready to finish up their paperwork. The problem? They should have gotten in touch with a lawyer at the beginning of the process. In this episode, we talk with two experts on the legal side of donor-assisted reproduction and adoption. We discuss why a call to a lawyer should come much earlier in these family-forming journeys — and how HR leaders can ensure their employees have the resources they need. Show notes: Why legal resources are a crucial part of fertility benefits PairTree: Connecting adoptive parents with birth moms International Fertility Law Group Little Fires Everywhere, by Celeste Ng
An overview of research on women who completed ICSI, IVF, and/or embryo transfer while actively or recently testing positive for SARS-CoV-2 (COVID-19).
Assisted reproductive technology has dramatically changed the concept of family. And it wasn't until the Child-Parent Security Act (CPSA) went into effect that the law in New York finally caught up with how children are being conceived. But what happens if the parents of a child conceived with assisted reproduction get divorced? Denise Seidelman is Cofounder of Rumbold and Seidelman, a firm specializing in adoption and reproductive law. She served on the Board of Trustees for the Academy of Adoption and Assisted Reproduction Attorneys and was one of three attorneys who drafted the CPSA. On this episode of Divorce Dialogues, Denise joins Katherine to share the definition of assisted reproduction and explain how it works biologically and legally. She describes how the Child-Parent Security Act revised parentage law, creating security for intended parents using assisted reproduction and making compensated surrogacy legal in New York. Listen in for insight into how assisted reproduction impacts marriages and find out what happens to a frozen embryo in the event of a divorce. Topics Covered The definition of assisted reproduction and how it works biologically and legally Why genetics is no longer a factor in determining who's a parent How the Child-Parent Security Act revised parentage law in New York State What the CPSA does to create security for parents of children conceived via assisted reproduction Examples of difficult legal cases involving sperm donors before the CPSA What it means to have a child through surrogacy How the CPSA made compensated surrogacy legal in New York The protections for surrogates and intended parents in the new law How assisted reproduction impacts marriages Denise's insight on what happens to a frozen embryo in the event of a divorce Connect with Denise Seidelman Rumbold & Seidelman: https://adoptionlawny.com/ Rumbold & Seidelman on Twitter: https://twitter.com/adoptionlawnynj Rumbold & Seidelman on Facebook: https://www.facebook.com/RumboldandSeidelman Connect with Katherine Miller The Center for Understanding Conflict: http://understandinginconflict.org/ Miller Law Group: https://westchesterfamilylaw.com/ Katherine on LinkedIn: linkedin.com/in/kemiller1 The New Yorker's Guide to Collaborative Divorce by Katherine Miller: https://www.amazon.com/New-Yorkers-Guide-Collaborative-Divorce/dp/0692496246 Email: katherine@miller-law.com Call (914) 738-7765 Resources The Child-Parent Security Act: https://www.health.ny.gov/vital_records/child_parent_security_act/
Tune in for an episode on “Current Trends” – specifically, this episode is about the intersection of assisted reproduction (i.e. IVF, IUI, surrogacy, etc.) and estate planning. Sources and episode transcript can be found at: LegalTeaPodcast.com.
Building a family with donor sperm is more common today than ever before. In this episode of Baby or Bust, Dr. Lora Shahine meets with the father of modern sperm donation, Dr. Cappy Rothman, who explores the past, present, and future of the sperm donation process.As the co-founder of California Cryobank, the world's largest sperm bank, Dr. Rothman has been at the forefront of assisted reproduction since its inception. Dr. Shahine and Dr. Rothman dig into the history of sperm banking (spoiler alert: The concept wasn't well-received when first shared in the 1950s) and his advocacy for sperm bank access for couples experiencing infertility. The episode also touches upon 23andMe and Ancestry.com's implications with donor anonymity, what people generally want in a donor, the information captured by sperm banks, and much, much more.You can learn more about Dr. Rothman here: https://www.laweekly.com/the-god-of-sperm/Connect with Dr. Lora Shahine on social media!Tik Tok | Instagram | Twitter | YouTube | LinkedInBaby Or Bust is Produced by Mark Ramsey, Jaime Solis, and Greg Moga. Executive Produced by Nick Panella, and Andrew Greenwood for Workhouse Media. Baby Or Bust is a Mark Ramsey Media production.
Building a family with donor sperm is more common today than ever before. In this episode of Baby or Bust, Dr. Lora Shahine meets with the father of modern sperm donation, Dr. Cappy Rothman, who explores the past, present, and future of the sperm donation process.As the co-founder of California Cryobank, the world's largest sperm bank, Dr. Rothman has been at the forefront of assisted reproduction since its inception. Dr. Shahine and Dr. Rothman dig into the history of sperm banking (spoiler alert: The concept wasn't well-received when first shared in the 1950s) and his advocacy for sperm bank access for couples experiencing infertility. The episode also touches upon 23andMe and Ancestry.com's implications with donor anonymity, what people generally want in a donor, the information captured by sperm banks, and much, much more.You can learn more about Dr. Rothman here: https://www.laweekly.com/the-god-of-sperm/Connect with Dr. Lora Shahine on social media!Tik Tok | Instagram | Twitter | YouTube | LinkedInBaby Or Bust is Produced by Mark Ramsey, Jaime Solis, and Greg Moga. Executive Produced by Nick Panella, and Andrew Greenwood for Workhouse Media. Baby Or Bust is a Mark Ramsey Media production.Advertising Inquiries: https://redcircle.com/brands
© 2020-2025 Ivy Podcast Discovery LLC
